Increased serum levels of soluble VE-cadherin might be a novel biomarker for evaluating the severity of Henoch-Schönlein purpura and useful for identifying the presence of SV in inflammatory skin conditions. PubMed, Rheumatol Int, 2014 Aug;34(8):1139-43. (Also see: Vasculitis)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.